Clinical Trial

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Study Description

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Alzheimer's disease (AD) is the most common cause of dementia and currently has no disease modifying treatments or simple accurate diagnostic tests. The goal of this project is to study how tau (a protein thought to cause AD) is made, transported and cleared in the human body. Better understanding of these processes may lead to improved understanding of AD, earlier diagnosis and a way to evaluate treatment.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

L-Leucine 13C6

Additional Information

Official Study Title

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Clinical Trial ID

NCT03938870

ParticipAid ID

egJPrd